On the origins and development of the 32P-postlabelling assay for carcinogen-DNA adducts

Cancer Letters

Volumn 334, Issue 1, 2013, Pages 5-9

  Phillips, David H ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Biomonitoring; Carcinogens; DNA adducts; Metabolic activation

Indexed keywords

ADENOSINE TRIPHOSPHATE; CARCINOGEN; PHOSPHORUS 32; DNA ADDUCT; PHOSPHORUS;

ANALYTIC METHOD; CARCINOGEN DNA INTERACTION; CLINICAL PROTOCOL; DNA DETERMINATION; GENOTOXICITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ISOTOPE LABELING; NONHUMAN; PRIORITY JOURNAL; PROCESS DEVELOPMENT; RADIOACTIVITY; RADIOASSAY; SENSITIVITY ANALYSIS; SHORT SURVEY; STANDARDIZATION; THIN LAYER CHROMATOGRAPHY; ANALYSIS; ANIMAL; DNA ADDUCT; ENVIRONMENTAL EXPOSURE; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STANDARDS;

ANIMALIA; ERICA;

ANIMALS; CARCINOGENS; DNA ADDUCTS; ENVIRONMENTAL EXPOSURE; HUMANS; ISOTOPE LABELING; PHOSPHORUS RADIOISOTOPES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84891912035     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2012.11.027     Document Type: Review

References (70)

1. 32P-Labeling test for DNA damage. Proc. Natl. Acad. Sci. USA 1981, 78:6126-6129.
2. 32P-Postlabeling analysis of non-radioactive aromatic carcinogen-DNA adducts. Carcinogenesis 1982, 3:1081-1092.
3. Randerath K., Randerath E. Postlabelling methods - an historical review. Postlabelling Methods for Detection of DNA Adducts 1993, 3-9. International Agency for Research on Cancer, Lyon. D.H. Phillips, M. Castegnaro, H. Bartsch (Eds.).
4. 32P-Base analysis of DNA. Anal. Biochem. 1981, 117:271-279.
5. 32P-Postlabeling analysis of DNA adducts persisting for up to 42weeks in the skin, epidermis and dermis of mice treated topically with 7,12-dimethylbenz[a]anthracene. Carcinogenesis 1985, 6:1117-1126.
6. 32P-postlabeling analysis of aromatic carcinogen:DNA adducts. Cancer Res. 1985, 45:5656-5662.
7. 32P-postlabeling test for structurally diverse DNA adducts. Carcinogenesis 1986, 7:1543-1551.
8. 32P-postlabelling assay after either 1-butanol extraction or nuclease P1 treatment. Cancer Lett. 1989, 45:7-12.
9. 32P-adduct assay: comparative recoveries of structurally diverse DNA adducts in the various enhancement procedures. Carcinogenesis 1988, 9:1687-1693.
10. 32P-postlabeling assay based on the specific enzymatic conversion of bulky DNA lesions to radiolabeled dinucleotides and nucleoside 5'-monophosphates. Carcinogenesis 1989, 10:1231-1239.
11. 32P-postlabeling analysis. Carcinogenesis 1988, 9:1055-1060.
12. Phillips D.H., Carmichael P.L., Hewer A., Cole K.J., Hardcastle I.R., Poon G.K., Keogh A., Strain A.J. Activation of tamoxifen and its metabolite α-hydroxytamoxifen to DNA-binding products: comparisons between human, rat and mouse hepatocytes. Carcinogenesis 1996, 17:89-94.
13. 2 atoms of guanine. Chem. Res. Toxicol. 1994, 7:752-761.
14. 6-methylguanine in DNA from human tissues. Carcinogenesis 1992, 13:469-475.
15. 32P-postlabelling. Carcinogenesis 1995, 16:613-617.
16. D.H. Phillips, M. Castegnaro, H. Bartsch, (Eds.), Postlabelling methods for detection of DNA adducts, Lyon, 1993.
17. 32P-postlabelling. Postlabelling Methods for Detection of DNA Damage 1993, 35-49. IARC, Lyon. D.H. Phillips, M. Castegnaro, H. Bartsch (Eds.).
18. Phillips D.H., Castegnaro M. Standardization and validation of DNA adduct postlabelling methods: report of interlaboratory trials and production of recommended protocols. Mutagenesis 1999, 14:301-315.
19. 32P-postlabeling assay for DNA adducts. Nat. Protoc. 2007, 2:2772-2781.
20. 32P-postlabeled DNA adducts. J. Chromatogr. B Biomed. Appl. 1996, 677:265-273.
21. 32P-postlabeling method. Carcinogenesis 1989, 10:1567-1577.
22. 32P-Post-labelling analysis of DNA adducts formed by food-derived heterocyclic amines: evidence for incomplete hydrolysis and a procedure for adduct pattern simplification. Carcinogenesis 1994, 15:877-882.
23. 32P-postlabeling assay. Mutat. Res. 1993, 288:5-18.
24. 32P-postlabeled DNA adducts. Carcinogenesis 1993, 14:1343-1348.
25. Nagy E., Cornelius M.G., Moller L. Accelerated (32)P-HPLC for bulky DNA adducts. Mutagenesis 2009, 24:183-189.
26. 32P-labelled nucleoside 3',5'-bisphosphate adducts of polycyclic hydrocarbons. J. Chromatogr. 1991, 570:65-76.
27. Phillips D.H., Hewer A., Horton M.N., Cole K.J., Carmichael P.L., Davis W., Osborne M.R. N-Demethylation accompanies α-hydroxylation in the metabolic activation of tamoxifen in rat liver cells. Carcinogenesis 1999, 20:2003-2009.
28. 32P-postlabeling assay for aromatic or bulky carcinogen-DNA adducts: evaluation of adduct recoveries in comparison with nuclease P1 and butanol methods. J. Chromatogr. 1993, 614:245-251.
29. 32P-Postlabeling/polyacrylamide gel electrophoresis analysis: application to the detection of DNA adducts. Chem. Res. Toxicol. 2002, 15:305-311.
30. Baird W.M., Lau H.H.S., Schmerold I., Coffing S.L., Brozich S.L., Lee H., Harvey R.G. Analysis of polycyclic aromatic hydrocarbon-DNA adducts by postlabelling with the weak ß-emitters 35S-phosphorothioate and 33P-phosphate, immobilized boronate chromatography and high-performance liquid chromatography. Postlabelling methods for detection of DNA adducts 1993, 217-227. IARC, Lyon. D.H. Phillips, M. Castegnaro, H. Bartsch (Eds.).
31. Kotova N., Hemminki K., Segerback D. Urinary thymidine dimer as a marker of total body burden of UV-inflicted DNA damage in humans. Cancer Epidemiol. Biomarkers Prev. 2005, 14:2868-2872.
32. Weinfeld M., Liuzzi M., Paterson M.C. Enzymatic analysis of isomeric trithymidylates containing ultraviolet light-induced cyclobutane pyrimidine dimers. II. Phosphorylation by T4 polynucleotide kinase. J. Biol. Chem. 1989, 264:6364-6370.
33. 32P-postlabeling of thymine glycol in γ-irradiated DNA. Carcinogenesis 1989, 10:43-47.
34. 32P-Postlabeling detection of thymine glycols: evaluation of adduct recoveries after enhancement with affinity chromatography, nuclease P1, nuclease S1, and polynucleotide kinase. Cancer Commun. 1991, 3:109-117.
35. 32P-Postlabeling detection of radiation-induced DNA damage: identification and estimation of thymine glycols and phosphoglycolate termini. Biochemistry 1991, 30:1091-1097.
36. Weinfeld M., Lee J., Ruiqi G., Karimi-Busheri F., Chen D., Allalunis-Turner J. Use of a postlabelling assay to examine the removal of radiation-induced DNA lesions by purified enzymes and human cell extracts. Mutat. Res. 1997, 378:127-137.
37. 32P-postlabeling assay for apurinic sites in DNA. Biochemistry 1990, 29:1737-1743.
38. 32P-postlabelling. Nucleic Acids Res. 1995, 23:1300-1306.
39. 32P-postlabelling assay for the quantitation of the major platinum-DNA adducts. Carcinogenesis 1997, 18:1767-1774.
40. 32P-postlabeling assay and the basal levels in rat tissues. Carcinogenesis 1996, 17:917-924.
41. 32PP-postlabelling approaches for the detection of 8-oxo-2'-deoxyguanosine-3'-monophosphate in DNA. Mutat. Res. 1997, 378:139-149.
42. Wilson V.L., Taffe B.G., Shields P.G., Povey A.C., Harris C.C. Detection and quantification of 8-hydroxydeoxyguanosine adducts in peripheral blood of people exposed to ionising radiation. Environ. Health Perspect. 1993, 99:261-263.
43. Gupta R.C., Arif J.M. An improved (32)P-postlabeling assay for the sensitive detection of 8-oxodeoxyguanosine in tissue DNA. Chem. Res. Toxicol. 2001, 14:951-957.
44. Jones G.D., Le Pla R.C., Farmer P.B. Phosphotriester adducts (PTEs): DNA's overlooked lesion. Mutagenesis 2010, 25:3-16.
45. 32P-postlabelling assay for the detection of alkylphosphotriesters in DNA. Carcinogenesis 1995, 16:1543-1548.
46. 32P-postlabeling for the detection of alkylphosphotriesters: evidence for the long-term nonrandom persistence of ethyl-phosphotriester adducts in vivo. Chem. Res. Toxicol. 2004, 17:1491-1500.
47. Randerath K., Randerath E., Zhou G.D., Li D. Bulky endogenous DNA modifications (I-compounds) -possible structural origins and functional implications. Mutat. Res. 1999, 424:183-194.
48. 32P-postlabeling assay for the oxidative DNA lesion 8,5'-cyclo-2'-deoxyadenosine in mammalian tissues: evidence that four type II I-compounds are dinucleotides containing the lesion in the 3' nucleotide. J. Biol. Chem. 2001, 276:36051-36057.
49. 32P-postlabelling of DNA adducts induced by a Fenton-type oxygen radical-generating system. Carcinogenesis 1992, 13:1127-1135.
50. Randerath K., Randerath E., Smith C.V., Chang J. Structural origins of bulky oxidative DNA adducts (Type II I-compounds) as deduced by oxidation of oligonucleotides of known sequence. Chem. Res. Toxicol. 1996, 9:247-254.
51. Carmichael P.L., Hewer A., Osborne M.R., Strain A.J., Phillips D.H. Detection of bulky DNA lesions in the liver of patients with Wilson's disease and primary haemochromatosis. Mutat. Res. 1995, 326:235-243.
52. Nair J., Carmichael P.L., Fernando R.C., Phillips D.H., Strain A.J., Bartsch H. Lipid peroxidation-induced etheno-DNA adducts in the liver of patients with the genetic metal storage disorders Wilson's disease and primary hemochromatosis. Cancer Epidemiol. Biomarkers Prev. 1998, 7:435-440.
53. Spencer W.A., Jeyabalan J., Kichambre S., Gupta R.C. Oxidatively generated DNA damage after Cu(II) catalysis of dopamine and related catecholamine neurotransmitters and neurotoxins: role of reactive oxygen species. Free Rad. Biol. Med. 2011, 50:139-147.
54. Spencer W.A., Vadhanam M.V., Jeyabalan J., Gupta R.C. Oxidative DNA damage following microsome/Cu(II)-mediated activation of the estrogens, 17beta-estradiol, equilenin, and equilin: role of reactive oxygen species. Chem. Res. Toxicol. 2012, 25:305-314.
55. Ravoori S., Vadhanam M.V., Davey D.D., Srinivasan C., Nagarajan B., Gupta R.C. Modulation of novel DNA adducts during human uterine cervix cancer progression. Int. J. Oncol. 2006, 29:1437-1443.
56. Phillips D.H. Understanding the genotoxicity of tamoxifen?. Carcinogenesis 2001, 22:839-849.
57. Poljakova J., Eckschlager T., Hrabeta J., Hrebackova J., Smutny S., Frei E., Martinek V., Kizek R., Stiborova M. The mechanism of cytotoxicity and DNA adduct formation by the anticancer drug ellipticine in human neuroblastoma cells. Biochem. Pharmacol. 2009, 77:1466-1479.
58. Arlt V.M. 3-Nitrobenzanthrone, a potential human cancer hazard in diesel exhaust and urban air pollution: a review of the evidence. Mutagenesis 2005, 20:399-410.
59. Arlt V.M., Stiborova M., Brocke J.V., Simoes M.L., Lord G.M., Nortier J.L., Hollstein M., Phillips D.H., Schmeiser H.H. Aristolochic acid mutagenesis: molecular clues to the aetiology of Balkan endemic nephropathy-associated urothelial cancer. Carcinogenesis 2007, 28:2253-2261.
60. Grollman A.P., Shibutani S., Moriya M., Miller F., Wu L., Moll U., Suzuki N., Fernandes A., Rosenquist T., Medverec Z., Jakovina K., Brdar B., Slade N., Turesky R.J., Goodenough A.K., Rieger R., Vukelic M., Jelakovic B. Aristolochic acid and the etiology of endemic (Balkan) nephropathy. Proc. Natl. Acad. Sci. USA 2007, 104:12129-12134.
61. Chen C.H., Dickman K.G., Moriya M., Zavadil J., Sidorenko V.S., Edwards K.L., Gnatenko D.V., Wu L., Turesky R.J., Wu X.R., Pu Y.S., Grollman A.P. Aristolochic acid-associated urothelial cancer in Taiwan. Proc. Natl. Acad. Sci. USA 2012, 109:8241-8246.
62. Phillips D.H., Schoket B., Hewer A., Grover P.L. DNA adduct formation in human and mouse skin by mixtures of polycyclic aromatic hydrocarbons. Complex Mixtures and Cancer Risk 1990, 223-229. IARC, Lyon. H. Vainio, M. Sorsa, A.J. McMichael (Eds.).
63. Phillips D.H. Smoking-related DNA and protein adducts in human tissues. Carcinogenesis 2002, 23:1979-2004.
64. Phillips D.H. Macromolecular adducts as biomarkers of human exposure to polycyclic aromatic hydrocarbons. The Carcinogenic Effects of Polycyclic Aromatic Hydrocarbons 2005, 137-169. Imperial College Press, London. A. Luch (Ed.).
65. Arif J.M., Dresler C., Clapper M.L., Gairola C.G., Srinivasan C., Lubet R.A., Gupta R.C. Lung DNA adducts detected in human smokers are unrelated to typical polyaromatic carcinogens. Chem. Res. Toxicol. 2006, 19:295-299.
66. 32P-Post-labelling method improvements for aromatic compound-related molecular epidemiology studies. Mutagenesis 2007, 22:381-385.
67. Veglia F., Loft S., Matullo G., Peluso M., Munnia A., Perera F., Phillips D.H., Tang D., Autrup H., Raaschou-Nielsen O., Tjonneland A., Vineis P. DNA adducts and cancer risk in prospective studies: a pooled analysis and a meta-analysis. Carcinogenesis 2008, 29:932-936.
68. Veglia F., Matullo G., Vineis P. Bulky DNA adducts and risk of cancer: a meta-analysis. Cancer Epidemiol. Biomarkers Prev. 2003, 12:157-160.
69. Gallo V., Khan A., Gonzales C., Phillips D.H., Schoket B., Gyorffy E., Anna L., Kovacs K., Moller P., Loft S., Kyrtopoulos S., Matullo G., Vineis P. Validation of biomarkers for the study of environmental carcinogens: a review. Biomarkers 2008, 13:505-534.
70. Harvey J.S., Lyons B.P., Waldock M., Parry J.M. The application of the 32P-postlabelling assay to aquatic biomonitoring. Mutat. Res. 1997, 378:77-88.